SCHOTT Pharma Supervisory Board extends contract of CEO Andreas Reisse and appoints Reinhard Mayer as new CFO

EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): Personnel/Contract SCHOTT Pharma Supervisory Board extends contract of CEO Andreas Reisse and appoints Reinhard Mayer as new CFO 11.06.2025 / 08:50 CET/CEST The issuer is solely responsible for the content of this announcement. SCHOTT Pharma Supervisory Board extends contract of CEO Andreas Reisse and appoints Reinhard Mayer as new CFO

• Andreas Reisse’s contract as CEO of SCHOTT Pharma extended
• CFO Dr. Almuth Steinkühler to leave the company at her own request to pursue new professional opportunities
• Reinhard Mayer appointed as new CFO of SCHOTT Pharma

The Supervisory Board of SCHOTT Pharma Management AG has decided to extend the appointment of Andreas Reisse as CEO of SCHOTT Pharma until April 2026. His contract will thus continue until he reaches the age limit of 65 years for members of the Executive Board, as stipulated in the Articles of Association. Andreas Reisse has been with the SCHOTT Group since 1987 and has led the “Pharmaceutical Systems” division since 2010, which has been listed on the Frankfurt Stock Exchange as SCHOTT Pharma AG & Co. KGaA since 2023. “Andreas Reisse has played a key role in developing SCHOTT Pharma into one of the world's leading pioneers in pharmaceutical containment solutions and delivery systems. We are delighted that he will continue to lead SCHOTT Pharma for another year, driving innovation and generating sustainable growth by expanding the company's global presence,” said Peter Goldschmidt, Chairman of the Supervisory Board of SCHOTT Pharma AG & Co. KGaA.

 “I would like to thank the Supervisory Board for their continued trust. Together, we have delivered industry-leading innovations, achieved remarkable growth, and improved the health of many people in a sustainable way. We have big plans for the future. Our sector remains dynamic and full of opportunity, and I look forward to working with the entire SCHOTT Pharma team to achieve our ambitious goals,” said Andreas Reisse, CEO of SCHOTT Pharma.